IE56844B1 - Phenethanolamine derivatives in weight control in animals - Google Patents
Phenethanolamine derivatives in weight control in animalsInfo
- Publication number
- IE56844B1 IE56844B1 IE3337/87A IE333787A IE56844B1 IE 56844 B1 IE56844 B1 IE 56844B1 IE 3337/87 A IE3337/87 A IE 3337/87A IE 333787 A IE333787 A IE 333787A IE 56844 B1 IE56844 B1 IE 56844B1
- Authority
- IE
- Ireland
- Prior art keywords
- feed
- animal
- improving
- animals
- compound
- Prior art date
Links
- 241001465754 Metazoa Species 0.000 title claims description 46
- ULSIYEODSMZIPX-UHFFFAOYSA-N phenylethanolamine Chemical class NCC(O)C1=CC=CC=C1 ULSIYEODSMZIPX-UHFFFAOYSA-N 0.000 title description 6
- 238000004260 weight control Methods 0.000 title description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 29
- 150000001875 compounds Chemical class 0.000 claims description 25
- 238000000034 method Methods 0.000 claims description 25
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 15
- 150000003839 salts Chemical class 0.000 claims description 15
- 239000002253 acid Substances 0.000 claims description 9
- 230000001737 promoting effect Effects 0.000 claims description 9
- 125000006308 propyl amino group Chemical group 0.000 claims description 7
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 claims description 6
- 241000282887 Suidae Species 0.000 claims description 5
- 235000019770 animal feed premixes Nutrition 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- 241000283690 Bos taurus Species 0.000 claims description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 39
- 239000000243 solution Substances 0.000 description 19
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- 239000000203 mixture Substances 0.000 description 18
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 16
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 15
- 241000282898 Sus scrofa Species 0.000 description 13
- 239000011541 reaction mixture Substances 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 229940126062 Compound A Drugs 0.000 description 9
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 9
- 239000004480 active ingredient Substances 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- 238000011282 treatment Methods 0.000 description 9
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical class O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 229910052757 nitrogen Inorganic materials 0.000 description 8
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 7
- 238000001704 evaporation Methods 0.000 description 7
- 230000008020 evaporation Effects 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 235000019198 oils Nutrition 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 229940088594 vitamin Drugs 0.000 description 7
- 229930003231 vitamin Natural products 0.000 description 7
- 235000013343 vitamin Nutrition 0.000 description 7
- 239000011782 vitamin Substances 0.000 description 7
- 150000003722 vitamin derivatives Chemical class 0.000 description 7
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 6
- 241000282849 Ruminantia Species 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 150000001412 amines Chemical class 0.000 description 6
- 229960002510 mandelic acid Drugs 0.000 description 6
- 235000012054 meals Nutrition 0.000 description 6
- 230000003287 optical effect Effects 0.000 description 6
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- DZGCGKFAPXFTNM-UHFFFAOYSA-N ethanol;hydron;chloride Chemical compound Cl.CCO DZGCGKFAPXFTNM-UHFFFAOYSA-N 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- -1 4-benzyloxyphenyl Chemical group 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
- 240000008042 Zea mays Species 0.000 description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 235000005822 corn Nutrition 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 125000004464 hydroxyphenyl group Chemical group 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 244000144977 poultry Species 0.000 description 4
- 235000013594 poultry meat Nutrition 0.000 description 4
- 239000011573 trace mineral Substances 0.000 description 4
- 235000013619 trace mineral Nutrition 0.000 description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 241000287828 Gallus gallus Species 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 239000007868 Raney catalyst Substances 0.000 description 3
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 3
- 229910000564 Raney nickel Inorganic materials 0.000 description 3
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 239000011260 aqueous acid Substances 0.000 description 3
- 235000021052 average daily weight gain Nutrition 0.000 description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 229930182817 methionine Natural products 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 239000011669 selenium Substances 0.000 description 3
- 229910052711 selenium Inorganic materials 0.000 description 3
- 229940091258 selenium supplement Drugs 0.000 description 3
- 235000019155 vitamin A Nutrition 0.000 description 3
- 239000011719 vitamin A Substances 0.000 description 3
- 229940045997 vitamin a Drugs 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 235000019786 weight gain Nutrition 0.000 description 3
- 230000004584 weight gain Effects 0.000 description 3
- WSKYXSVLAFGEJW-UHFFFAOYSA-N 3-(4-phenylmethoxyphenyl)propan-1-amine Chemical compound C1=CC(CCCN)=CC=C1OCC1=CC=CC=C1 WSKYXSVLAFGEJW-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 241000283903 Ovis aries Species 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 235000019764 Soybean Meal Nutrition 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 239000004182 Tylosin Substances 0.000 description 2
- 229930194936 Tylosin Natural products 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- 230000001195 anabolic effect Effects 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 235000021050 feed intake Nutrition 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 229940055726 pantothenic acid Drugs 0.000 description 2
- 235000019161 pantothenic acid Nutrition 0.000 description 2
- 239000011713 pantothenic acid Substances 0.000 description 2
- FDPIMTJIUBPUKL-UHFFFAOYSA-N pentan-3-one Chemical compound CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 229950006768 phenylethanolamine Drugs 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000004455 soybean meal Substances 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- WBPYTXDJUQJLPQ-VMXQISHHSA-N tylosin Chemical compound O([C@@H]1[C@@H](C)O[C@H]([C@@H]([C@H]1N(C)C)O)O[C@@H]1[C@@H](C)[C@H](O)CC(=O)O[C@@H]([C@H](/C=C(\C)/C=C/C(=O)[C@H](C)C[C@@H]1CC=O)CO[C@H]1[C@@H]([C@H](OC)[C@H](O)[C@@H](C)O1)OC)CC)[C@H]1C[C@@](C)(O)[C@@H](O)[C@H](C)O1 WBPYTXDJUQJLPQ-VMXQISHHSA-N 0.000 description 2
- 229960004059 tylosin Drugs 0.000 description 2
- 235000019375 tylosin Nutrition 0.000 description 2
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- IWYDHOAUDWTVEP-SSDOTTSWSA-N (R)-mandelic acid Chemical class OC(=O)[C@H](O)C1=CC=CC=C1 IWYDHOAUDWTVEP-SSDOTTSWSA-N 0.000 description 1
- QHGUCRYDKWKLMG-QMMMGPOBSA-N (R)-octopamine Chemical compound NC[C@H](O)C1=CC=C(O)C=C1 QHGUCRYDKWKLMG-QMMMGPOBSA-N 0.000 description 1
- ADFXKUOMJKEIND-UHFFFAOYSA-N 1,3-dicyclohexylurea Chemical compound C1CCCCC1NC(=O)NC1CCCCC1 ADFXKUOMJKEIND-UHFFFAOYSA-N 0.000 description 1
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
- AEDORKVKMIVLBW-BLDDREHASA-N 3-oxo-3-[[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-[[5-hydroxy-4-(hydroxymethyl)-6-methylpyridin-3-yl]methoxy]oxan-2-yl]methoxy]propanoic acid Chemical compound OCC1=C(O)C(C)=NC=C1CO[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](COC(=O)CC(O)=O)O1 AEDORKVKMIVLBW-BLDDREHASA-N 0.000 description 1
- BZENRVUXKMEUBO-UHFFFAOYSA-N 4-(oxiran-2-yl)phenol Chemical compound C1=CC(O)=CC=C1C1OC1 BZENRVUXKMEUBO-UHFFFAOYSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- YHXHKYRQLYQUIH-UHFFFAOYSA-N 4-hydroxymandelic acid Chemical compound OC(=O)C(O)C1=CC=C(O)C=C1 YHXHKYRQLYQUIH-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 241000273930 Brevoortia tyrannus Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- QPLDLSVMHZLSFG-UHFFFAOYSA-N Copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 description 1
- 239000005751 Copper oxide Substances 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 240000004658 Medicago sativa Species 0.000 description 1
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 1
- 101100128278 Mus musculus Lins1 gene Proteins 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- YNPNZTXNASCQKK-UHFFFAOYSA-N Phenanthrene Natural products C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- AWMVMTVKBNGEAK-UHFFFAOYSA-N Styrene oxide Chemical compound C1OC1C1=CC=CC=C1 AWMVMTVKBNGEAK-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 235000019742 Vitamins premix Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 1
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Substances CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
- 229940073608 benzyl chloride Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940036811 bone meal Drugs 0.000 description 1
- 239000002374 bone meal Substances 0.000 description 1
- 229910000085 borane Inorganic materials 0.000 description 1
- MCQRPQCQMGVWIQ-UHFFFAOYSA-N boron;methylsulfanylmethane Chemical compound [B].CSC MCQRPQCQMGVWIQ-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 239000012050 conventional carrier Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910000431 copper oxide Inorganic materials 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 235000020997 lean meat Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000020442 loss of weight Diseases 0.000 description 1
- 229960003646 lysine Drugs 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- NJGBTKGETPDVIK-UHFFFAOYSA-N raspberry ketone Chemical compound CC(=O)CCC1=CC=C(O)C=C1 NJGBTKGETPDVIK-UHFFFAOYSA-N 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229940040944 tetracyclines Drugs 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
This invention relates to phenethanolamine derivatives in weight control in animals.
The chemist ry and use oi ^-phen&th&nol&mines has been extensively investigated. European Patent Specification Ho. 6p7a6 describes the use of phenethanolamine derivatives in promoting the loss of weight in animals.
This invention provides a method for increasing weight gain in domestic animals and improving the efficiency of feed utilisation fend the quality of the carcass. The invention is more particularly directed to a method for promoting growth, improving feed efficiency or leanness comprising administering a cos^ound having the toraula (ϊ) 0H CH.
HO OH (X) Our Patent discloses or an acid addition salt thereof.
Specification No. λ ///< c, the use of related compounds.
This invention also provides an animal feed 20 premix comprising a β-phenethanolamine of the above formula together with a suitable carrier therefor.
The compound of formula (I) is disclosed as having utero-relasting activity by Van Dijk et al. in Recueil, 92 1281 (1973>.
The compound of formula (X) can be prepared by reaction of a styrene oxide with & 3-pheny Ipropylamine derivative.
An alternative method for preparing the 0^phenethanolamine comprises reacting a mandelic acid derivative with a 3-pheny Ipropy lamine derivative to provide an eamidetf which upon subsequent reduction compound of the &bove formula * A similar, yet alternative, method of synthesis comprises reacting a phenethaaoXamiae with a phenyl Thus, 2»bydroxy2-(4-hydroKyphuyX)$thylemino can be reacted with a ketone such as methyl 2-(4-hydroxyphenyl) =· ethyl ketone to provide the corresponding imine, which upon reduction, for instance with 5¾ palladium on carbon, provides 1- (4-hydroxyphenyl) -2® (l-methyi-3- (4~hydro2cy~ phenyl) propy lamino) ethanol.
Xt should be noted that the compounds to be employed in this invention possess two asymmetric centers ® Since employment of individual optical isomsrs necessitates preparing the e-pheMthanolamines from optically active starting materials, or using costly separation procedures, a preferred embodiment of this invention for veterinary purposes (employs a mixture of optical isomers<. Thus, 1- (4-hydroxyphenyl )-2-( 1-methy I® 3- (4-hydroxyphenyl) propyXamino)ethanol is preferably prepared from racemic- mixtures of starting materials, e.go dl-l-methy 1-=3-(4-hydroxyphenyl>propylamine and dl-4-hydroxy styrene oxide, to provide a t mixture of all four possible optical isomers of the product. The mixture of optical isomers is employed in the method without subsequent separation of isoxvers® Since the 0-phenethanolamine to be employed in the present method is inherently basic, it readily forms acid addition salts with any number of inorganic and organic acids® These salts can be employed in the invention, and often are preferred to the free base since they generally ©re more soluble in solvents such as water and are store conveniently formulated as an animal feedstuff.
Acids eo5feroaly es^ployed to form ©cid addition salts include mineral acids such as hydrochloric acid, sulfuric acid, phosphoric &cid, perchloric acid and the like? and organic acids such as acetic acid. citric acid, succinic acid, para*t©Xuene sulfonic acid. methanesulfonic acid, lactic ecid &nd the like. Preferred salts to be employed in the present method include the hydrochlorides &nd hydrobromides.
Th^ method of promoting growth &nd improving leanness and feed efficiency provided by this invention is practised by administering an effective amount of & · compound of formula (1) to a domesticated animal that receives a nutritionally adequate diet. The term domesticated animal as used herein includes those * warm-blooded animals raised for human meat consumption, for exaaple grouer/finisher swine, poultry, ruminants and the like, but excludes such animals as rats. In a preferred embodiment, the growth of pigs, chickens and turkeys is promoted employing a β-phenethanolamine.
Another preferred embodiment is practiced in ruminants such as cattle, sheep and goats. The method of improving leanness is not limited to meat producing animals, and can be practiced on other warm-blooded animals, including docs and cats. This latter embodiment is particularly useful when it is desired to maintain mature animals in a relatively lean physical state.
The method of the invention is preferably practiced by orally administering an effective amount of a β-phenethanolamine to an animal. Other routes of administration can be employed, for instance intra« muscular or intravenious injection; however, such routes are less practical. The amount to be administered to an animal is the amount that is effective in causing * g a promotion of growth, or an improvement in the efficiency of utilisation of food, or an improvement in carcass guality of the animal, for instance in the form of less fatty tissue and improved leanness. The effec5 tive amount to be administered will vary somewhat depend» ing upon the particular animal species being treated and the particular active ingredient employed, hut generally will be from about 1 to about 1000 parts per million (ppm) of total daily feed intake. Such amount will provide a dosage of about 0.05 to about 50 mg/kg. A preferred embodiment employs about 1 to about 200 ppm, and more preferably from about 5 to about 100 ppm. A typical amount of active ingredient to be administered to swine will be from about 5 to about 40 ppm. For example, when practicing the method in animals such as ruminants or swine, the compound will be added to the daily feed ration at about 5 to about 100 parts per million of the daily feed ration.
For oral administration, the active β-phen» ethanolamine is preferably admixed with suitable carriers or diluents commonly employed in animal husbandry. Animal feed premixes comprising a p=-phenethanolamine as defined herein are provided as a further embodiment of this invention. Typical carriers and diluents commonly employed in such feedstuffs include com meal, soybean meal, alfalfa meal, rice hulls, soybean mill run, cottonseed oil meal, bone meal, ground com, corncob meal, sodium chloride, urea, cane molasses and the like.
* Such carriers promote a uniform distribution of the active ingredient in the finished feed ration into which such compositions are added, thereby ensuring proper distribution of the active ingredient throughout the feed. The feedstuff composition provided by the invention will contain about 5 to about 95 percent by weight of active ingredient, and more typically about 10 to about 50 percent by weight. As already noted, the acid addition salts of the active phenethanolamines are generally preferred for oral administration, and are thus the preferred form of active ingredient for the feedstuff compositions of the invention.
While the preferred method for orally administering the growth promoters is via the daily feed rations, the compounds can be incorporated into salt blocks and mineral licks, as well as being added directly to drinking water for convenient oral consumption. The compounds can additionally be formulated with polymorphous materials, waxes and the like for long-term controlled release, and administered to an animal as a bolus or tablet only as needed to maintain the desired daily payout of active ingredient.
For parenteral administration, the β-phenethanolamines can be admixed with conventional carriers such as com oil, sesame oil, carbowax, calcium stearate and the like. Such formulations can be molded into pellets and administered as an injection or as a slow-re™ lease subcutaneous implant. Such administrations can be made as often as needed to ensure the proper dosing of active ingredient to obtain the desired rate of growth promotion and improvement in leanness and feed efficiency. β 5 While the compounds described herein are effective in promoting average daily weight gain and improving feed efficiency in animals, they also cause < observable improvement in the quality of the meat produced. ' For example, the compounds appear to mobilise free fatty acids from fatty tissue and depress the deposition of fat as the animals gain weight. This reduction of fat is beneficial since the animal being treated according to the invention gains weight in the form of more useable lean meat, thereby reducing waste and improving the value of the animal thus treated.
Also, mature animals that are not subject to additional f weight gain can be maintained in a desirably lean form by administering a compound as described herein.
The practice of the present invention is more fully illustrated by the following detailed examples.
Example 1 Preparation of dl-4~(benzyloxy)mandelic acid A solution of 5.0 g of dl-4-hydroxy mandelic acid, 11.0 g of benzyl chloride and 10.0 g of potassium carbonate in 50 ml of methanol was heated to reflux and stirred for seventy-two hours. The reaction mixture was cooled to room temperature and diluted with 50 ml of water. The aqueous solution was washed twice with 50 ml portions of benzene, and then was acidified with concentrated hydrochloric acid. The aqueous acid solution was extracted three times with 50 ml portions of ethyl acetate. The organic extracts were combined, washed with water and with saturated sodium chloride solution and dried. Removal of the solvent by evaporation under reduced pressure provided 5.7 g of a solid which was then recrystallized from 300 ml of toluene to afford 5.33 g of 31-4-(benzyloxy)mandelic acid. itf.P. 153-155°C.
Analysis calc, for C15H14O4 Theory: C, 69.76; H, 5.46; Found : C, 69.96; H, 5.33.
Example 2 Resolution of 31-4~(benzyloxy)mandelic acid to provide R(-)"(4-benzyloxy)mandelic acid To a stirred solution of 185.6 g of dl-4benzyloxy)mandalic acid in 2500 ml of ethyl acetate at 80°C was added in one portion 43.6 g of R(*)-a-methylbenzylamine. The reaction mixture was cooled to room temperature, and the precipitated solid which had formed was collected by filtration and washed with frssh ethyl acetate. The solid was recrystallised twice from a solution of ninety percent ethanol in water to provide 91.4 g of the RpJ-ff-raethylbensylamiae salt of R(-)"4-(hensyloxy)aandelic acid. W.P. 208.5" 209,5°C. [Q -38.6°, [«]365 -155.3° (HeOB) Analysis calc, for C23H25ftOA Theory: 0, 72.80; H, 6.54; H, 3.69; Found : C, 72.95; H, 6.83; H, 3.95.
To a stirred suspension of 91.4 g of the above-named salt in 2000 ml of ethyl acetate was added 150 ml of ten percent aqueous hydrochloric acid solution. The aqueous acid solution was separated, and the organic layer washed with water and dried. Removal of the solvent by evaporation under reduced pressure afforded 54.5 g of H(-)-4-(bensyloxy)mandelic acid, ie. R( - )-2- (4-benzyloxyphenyl, -2-hydroxyacetic acid. v?. P. 155-161°C. [a]D -102.2°; f365 -410.6° (^eOH) Analysis calc, for C15H14°4 Theory: C, 69.76; H, 5.46; Found : C, 69.67; H, 5,41.
Example 3 Preparation of dl«l«methyl^3"(4-benzyloxyphenyl)propyl-’ amine A solution of 40.0 g of methyl 2"(4-bensyloxyphenylJethyl ketone and 160 ml of anhydrous ammonia in 300 ml of ethanol was heated at 75°C and stirred for two hours. After cooling the reaction mixture to room temperature, 4.0 g of Raney nickel was added in one portion, and the reaction mixture then was stirred at 25°C for twelve hours under a hydrogen atmosphere at 300 psi. The reaction mixture next was filtered and the filtrate was concentrated by evaporation of the solvent under reduced pressure to provide an oil. The oil was dissolved in 120 ml of 3W hydrochloric acid, from which the product as a hydrochloride salt precipitated. The salt so formed was collected by filtration and recrystallized from methanol and toluene to provide 36.2 g of dl-l~methyl-3~(4-benzy loxyphenyl )propylaminium chloride, M.P. 195-197.5°C.
Example 4 Resolution of dl«l-methyl-3-(4~benzyloxyphenyl)propylamine to provide R-(-)-1 -methyl-3-(4-benzyloxyphenyl)" propylamine A solution of 629,3 g of dl-l®methyl-3-(4bensy loxyphenyl )propylaminium chloride was converted to the free amine by reaction with 95 g of sodium hydroxide in 400 ml of water. The free aiaine was then dissolved in 2000 ml of methylene chloride and added to a solution of 328 g of 0-(-)-mandelic acid in 1000 ml of methanol.
The mandelic acid salt of the free amine precipitated out of solution and was recrystal lised three times from methanol to provide 322 g of the R-mandelic acid salt of R-l-methyl-3«(4-bensyloxypheayl)propylamine. H.P. X66~167°C. (a]D -30°, [365^ 119° (MeOH).
The salt so formed was converted to R~X*methyl-3°(4-bensyloxypheayl )propylamine as the free base by reaction with aqueous sodium hydroxide.
Example 5 R, r-k- [2- (4-Bensyloxyphenyl )-2-hydroxy-l-oxoethyl) -115 methyl-3 (4~bensy!oxypheayX )propylamine A solution of 93.9 g of Ρ-1«Β©ΐΛιγ1<*3-(4benzyloxyphenyl)propylamine in 500 ml of N,N~dimethyl« formamide containing 63.0 g of 1-hydroxybenzotriazole and 104.6 g of n-2-(4«bensyloxyphenyl)-2-hydroxyacetic acid was cooled to 0°C and stirred while a solution of 83.6 g of N,Ν'-dicyclohexylcarbodiimide in 300 ml of dimethylformamide was added dropwise over one hour.
The reaction mixture was stirred for twelve hours at 3°C and then was diluted with 10 ml of water, stirred for an additional hour, and then cooled to -30°C in an ice-acetone bath. The reaction mixture was filtered to remove dicyclohexylurea, and then the filtrate was concentrated by evaporation of the solvent under reduced pressure. The concentrated solution was diluted with ethyl acetate and washed with saturated aqueous sodium carbonate solution, with water, with 300 ml of IN hydrochloric acid, and again with water. The organic layer was dried and the solvent was removed by evaporation under reduced pressure to provide the product as a white solid. The solid was recrystallized once from acetonitrile and again from methanol to provide 159.7 g of R, R-N- [ 2™(4-bensy loxyphenyl) -2-hydroxy-l-oxoethyl ] methyl-3-(4-bensyloxyphenyl Jpropylamine. M.P. 145-148°C. [a]D "15.9°, [a)365~50.1° (MeOH).
Analysis calc for C32S33^°4 Theory: C, 77.55? H, 6.71? N, 2.83; Found : C, 77.04; H, 6.84; N, 2.53.
Example 6 R,R«N~[2-(4-Benzyloxyphenyl)-2-hydroxyethyl]-1-methyl3 - (4-bensy loxyphenyl )propylamine To a stirred solution of 10.0 g of R,R-N-[2(4-benzyloxyphenyl) -2-hydroxy~l-oxoethyl ] ~l-methyle3" (4-benzyloxyphenyl )propylamine in 500 ml of freshly distilled tetrahydrofuran under a nitrogen gas atmosphere was added dropwise over thirty minutes 41 ml of 2 molar borane-dimethyl sulfide complex in tetrahydro13 furan- The reaction mixture was stirred at 25°C for twenty hours, and then was heated to reflux and stirred for an additional three hours. After cooling the reaction mixture to 25°C and stirring for another eighteen hours, the excess borane was decomposed by the slow portion-wise addition of 400 ml of methanol. The solvent was then removed from the reaction mixture by evaporation under reduced pressure to provide the product as an oil. The oil so formed was dissolved in 250 ml of hot methanol, and after concentrating the volume to 125 ml, the product began crystallising out of solution. The crystalline product was collected by filtration and recrystallised twice from methanol to provide 6.65 g of 8,R-N-[2-(4~bensyloxyphenyl) ’2-hydroxyethyl ] ®l-methyl-3-(4-bensyloxyphenyl )propylamine.
M.P* 119-123.5°C.
The amine so formed was dissolved in methanol and a^dded to a solution of ethereal hydrogen chloride, thereby providing 6,49 g of R,R™N-[2"(4-benzyloxyphenyX)2-hydroxyethyl ] "l=-methyl-3- (4-benzyloxyphenyl )propylaminium chloride. H.P. 214.5-216eC. [cr]p -13-4°, [ff]365 "30.2° (MeOH).
Analysis calc, for C^H^itfO^Cl Theory: C, 74,19; H, 7.00; N, 2.70; Cl, 6.84; Found : C, 74.20; H, 6.98; W, 2.65; Cl, 6.63. id Example 7 R,R-l-(4~Hydroxyphenyl)-2-[l~methyl-3-(4»hydroxyphenyl)* propylamino]ethanol hydrochloride, also named as R,R-M(2~(4«Hydroxyphenyl)-2-hydroxyethyl ] -1-methyl-3- (4hydroxyphenyl )propylaminium chloride A mixture of 51.6 g of R,R^M~[2"(4-benzyloxyphenyl)"2-hydroxyethyl]l"methyl-3-(4benzyloxy- » phenyl)propylaminium chloride and 5.0 g of Raney nickel in 2 liters of ethanol and 2 liters of ethyl acetate was stirred at 25°C for four and one-half hours under a hydrogen atmosphere of 60 psi. The reaction mixture was then filtered to remove the residual Raney nickel, and the filtrate was concentrated to an oil by evaporation of the solvent under reduced pressure, and the oil was crystallized from fresh ethanol and diethyl ether to provide 29.8 g of R,R-N-(2-(4-hydroxyphenyl)-2hydroxyethyl]l-methyl-3- (4-hydroxyphenyl)propylaminium chloride. M.P. 176-176.5eC. (dec.) (α]ρ -22.7°, (ff]365 -71.2° (3.7 mg/ml MeOH).
Analysis calc, for C18H24NO3C^ Theory: C, 63.99; H, 7.16; M, 4.15; Found : C, 63.70; H, 7.26; H, 4.32. is Example 6 As pointed out above, & preferred embodiment of this invention employs a mixture of all four optical isomers of the compound of Example 7. This racemic mixture can be prepared by the method described above by reaction of dl'-4"(bensoyloxy)mandelic acid with dl1- methyl-3-(4-bea3yloxyphenyl)propylamiae in the presence of DCC to give racemic l»(4*bensyloxyphenyl)-2-oxo2- [ 1-methyl-3- (4-benxyloxyphenyl )propylamino ] ethanol.
Reduction of the latter compound and subsequent removal of the bensyl groups provides racemic 1®(4-hydroxyphenyl) -2- [l-methyl-3- (4-hydroxyphenyl Ipropylamino] ethanol. This compound is more preferably prepared by the following procedure.
A solution of 32.8 g (0.2 m) of methyl 2-(4hydroxyphenyl)ethyl ketone and 42.6 g (0.2 in) of 1-(4hydroxyphenyl)-2-aminoethanol in 380 ml of ethanol containing 3.8 g of five percent palladium on carbon was stirred for sixteen hours at 60°c under hydrogen at 55 psi. The reaction mixture was then filtered, and the filtrate was diluted by addition of 350 ml of water.
The aqueous mixture was concentrated to a volume of about 400 ml, and then washed with dlchloromethane.
The aqueous mixture was acidified by addition of 50 ml of cone, hydrochloric acid. After standing at room temperature for two hours, the aqueous acid mixture was filtered and the filter cake was washed with 40 ml of IS ice water find dried et 50cC in vacuum to provide 47 g of l-(4‘*hydroxnjheny2"2H-mn»ethy3"3~Hhydroxyphenyl )propylamino)ethanol hydrochloride. M.F. 124-129CC.
Analysis c&lc. for Theory: C. 63.99; H. 7.16: H, 4.15; Cl, 10.49. Found: C, 63.77; Η, δ.Θ0; W, 3.91; Cl. 10.66. 13 C NMR studies demonstrated the product to be com- prised of 51^ RR,$S diastereamer and $9% RS, SR diastereomer. gxample, 9 Fremix for $v«ne Ingredient X by weight 1»(4-hydroxyphenyl)-2~(1-methylθ 10 3-(4~hydroxyphenyl)propylamino] ethanol hydrochloride Soybean mill run €$ Mineral oil _2 100 The above ingredients are blended tc uniformity to provide a dry flowable premix that can be admixed with a typical animal feed ration at a rate to provide about 20 ppm of active ingredient in the final feed ration. For example, the premix can be added tc the following swine grower ration for convenient oral administration of the f^pbenethanolamine to swine.
Ingredient Tt, by wijjoht Ibs/Ton l9/t Corn, yellow, ground 76.70 153« 767 Soybean Oil Keel, solvent extracted, detailed 19.35 387 194 5 Calcium Carbonate 1.20 24 12 4 Dicaleium Phosphate, feed grade 1.20 24 12 Salt (sodium chloride) 0.30 IO $ Trace mineral premix, A$~03" o.io 2 1 w 10 Swine Vitamin Premia, sw-032 0.65 13 7 Vitamin & Premia, 3M use units/lb.3 0.05 1 <£> 0.5 Methionine Hydroxy Analogue, 93% 0.2Q 4 2 15 Selenium Premix^ 0.006 .....1 0.5 100.00 2000 1000 ^Eoch Kg of premia contains: 50 g manganese as manganese sulfate; 100 g sine as sine carbonate; 50 g iron as ferrous sulfate; S g copper os copper oxide; 1.5 g iodine as potassiiyn iodide and 150 g maximum and 130 g minimum calcium, as calcium carbonate. "i "Each Kg of prexix contains: 77,161 10 Vitamin D2; 2.205 IU Vitamin E; 411 ©g riboflavin; 1,520 mg pantothenic acid; 2,205 mg niacin; 4.4 mg vitamin BiS; 441 mg Vitamin K; 19,100 mg choline; 110 mg folic acid; 165 mg pyridoxine; 110 sg thiamine; 22 sg biotin.
Each Kg of premix contains 6,613,800 XU vitamin A.
^Each Kg of preaix contains 200 mg of selenium as sodium selenite. ϊ@ A ten day in vivo study was employed to determine the effect of β-phenethanelamines on feed efficiency and rate of growth. In these studies, barrows and gilts weighing approximately 60 Mg were maintained in individual pens. Each treatment was replicated six times in randomly assigned animals, with each test animal forming an experimental unit. A group of control animals received a normal swine grower feed ration comprising the following ingredients: Inorodient 1 by weight Ground yellow corn 76.70 Soybean oil meal 19.35 Calcium carbonate 1.20 Dicaleium phosphate 1.20 Sait 0.50 Trace mineral premix 0.10 Swine Vitamin premia 0.65 Vitamin A premia, 3K USP units/lb. 0.05 Methionine Hydroxy analogue, 93% 0.20 Selenium premix20S 100.00 The test animals received the same feed ration plus the test compound. All animals received feed and «ater ad libitum. All animals were weighed on day 1 and again on day 10, and feed consumption was measured by recording all feed issued and any remaining feed on day 10. The results of two series of this XQ day test are given in Table L In the © ί Table, the column labelled AIX" is the average daily weight gain in kilograms and pounds; mA£)Fw is the average daily feed consumption (in kilograms and pounds) by the test animals; and F/G is the feed efficiency calculated as ADF divided by ADG.
I e Cj © rtj fe cs cs |oa cm © tfi •«4 W fO &> r· c* OM · · xlo © © © •op O' «— CM © A to EW Xi © © fe Ό C »5 C c £ aa &, £ aJ u C o The β-phenethanol amines to be employed in the method of this invention can be administered in combination with other compounds known to have a beneficial effect upon animals. typical compounds to be co-edmin5 istered with 'the p-pheaetbanolami&eo include antibiotics, for exanple any of the tetracyclines· tylosin, penicil® lins. cephalosporins, polyether antibiotics, glyeopeptides, orthosoaycins &nd related compounds commonly administered to swine, poultry, ruminants and the like.
A preferred combination to be employed in the present method is an antibiotic such as tylosin or a t^tra® eyeline, together with 1®(4-hydroxyphenyl)®2-[1-methyl® 3»(4«hydroxypbenyl)p?opylamino)ethanel - Such combinations will comprise the respective components in a ratio of about 1 to about 2 parts by weight ©f P<»phenethanolaaine and about 1 to about 10 parts by weight of the partner component.
A total of 100 crossbred barrows and gilts, averaging approximately 134 pounds starting weight, were used to determine the effect of oral administration of Example.- 6 at 5 or 20 ppm on growth performance &nd carcass characteristics of finishing pigs. Ths pigs were fed a 16X crude protein corn-soy diet during the experiment fend wers boused in fen on25 closed commercial type swine building with concrete slatted floors. The effect of treatments on average daily gain (ADG), average daily feed (AX>F) and feed/gain are shown in Table 11. The treatment effects on the carcass composition of the pigs presented in Table XSS. <ί) ·Η «) «ϊ Ο «Α « η ng ca <1 η Ό ca *< Α» ο «η «» η Ci η αι β Η «Λ ΙΑ ιπ fe- ι ο «0 Ω ng> Ο «V «ζ • • 4<1 «Μ 04 ca 03 oa ΑΙ ΐΑ Μ> fM| • β . g «-4 6* 1 <9 fA η 51 ♦0 Α» ο» • Ο Ο Ο «Μ f*i ΑΙ «0 «J *Η| ο <Ά rn •Η <[» β» «— f*ft 44 Α ·*4 • <0 E* C ff*a si »-β· 1 V? CJ VS 03 Μ» >»© ε=μ Μ &* «4 «J C ι3 © « & U *** •eft fiX «s? tS3 » «μ» >> ki Φ A £ F~1 S Ή G ο & CM «— C Ο © fi£ α α α α ΙΑ ο 03 α> βΜ Φ φ Ο «Η •Η fcjf α α £J ε ε £ «Β <9 0 Κ « υ Μ ea A >1 β <8 (Ε α jSj •c=4 Ο «§* W Φ 09 ΛΜ .υ «J 0 <3 β Φ C (3 5^ ,.pj &J GS « J0 η Ο £ & Μ © > >, υ ο fel C «Ο A 40 Φ Β* £ «Η 44 ·*4 © «9 ¢3 £ Φ 44 ε «Φ ο β υ 6= ο 0 Θ) & Ό «© Μ <1> Φ ω W Ν & > <Η <Μ & S A ¢-1 φ Μ> ί® 44 5 ε <3 & •Η Φ ρ»4 β U Μ < ΑΑ & (Μ Sm • ρ=4 0 » «3 38 T? & Τ> θ 3 c «—a Q «3 & & β '·© •βΜ Ο ο β Μ φ & €\3 « S3 (Z& .
• J » 5- ** co t*J & SE • O &?j ¢3 m co » m £ «; Ef j £rj · «£ & <*! «Α sB fej β ol co fe. ft TA3LE III • · « t^l fsl fe3 fi. mJ > S’ » nc «e I K «C fo W OOM ec 2 <3 ta) X o u G ra ra a k Q I © Cm ΜΊ la) H »J 1 e • > > L·) («il © raw ^M <4 <£ Μ 1 Ρ» Pfo r. fo 1 ra raW © ra •M J M > **. > Μ O «2 *J feS €9 Ifl gi ra «Η ¢£.
•M i»)O IH w § Gti) &» >8 ά* (3 *C3 <0 (M 10 fe. <8 ca fe <8 t=4 «3 0 « fja oM ¢0 «) » & S9 &· (0 m X «; ¢9 tei /« ffl HI III fol «, &4 e fo o fo ejI e to Ml «5 («3 &3 Additional studies have been carried out to demonstrate the anabolic effect of p-phenetbanolamines in swine. The effect of the compounds on nitrogen retention in finishing barrows was determined. nitrogen retention is the difference between nitrogen intake and nitrogen excreted. Increased nitrogen retention is 'mown to he associated with increased anabolic activity, resulting in improved carcass muscling and leanness.
In a typical study, harrows weighing about 172 pounds (78 Kg) were orally administered various doses of l"(4hydrcxyphenyl)-2"ll-methyl®3-(4«hydroxyphenyl )propvlejnino]ethanol hydrochloride (Compound A). All animals received ^eter and e constant emount of normal swine feed ration. The results of this study are presented in Table iv, and show that all p^phenethanol amine treatments improved nitrogen retention compared to controls.
Table iv Treatment Nitrogen detention Animals per Ki treatment trogen Retained (g/ Control Compound A (5 g/T) Compound A (10 g/T) Compound A (20 g/T) 21.0 23.5 23.9 .0 As pointed out ftbovs, the method of this invention can be practiced with individual isomers of β-pbenethanolamnes or with mixtures of isomers and diastereomers. in a study to determine the effect on weight gain and feed efficacy pf various mixtures of diastereomers, borrows initially weighing about 177 pounds (80 kg) were fed a normal swine diet plus & @-phen~ ethanolamine at 20 g/T oi feedstuff. Each treatment was replicated in twelve individually fed animals. The results are presented in Table V ©nd show that growth performance was improved by both p-phenethanolemiae treatments with very little change ia feed intake. •«Μ φ & e? Θ' ss Φ Ε GJ «3 > Ο &* <=« OS O*r*J JZ Βί9> Ο tft θ' « CD CD Ο > & ι=4: & IU ί >) 1 <3 Ο C' ν& & .Qto & & φ ®-«Γ· • • θ' fcf» tn tn (3 Ό ϊτί Φ φ Φ > k, «£ σ^> ο MD -hike νο VD 04 03 04 ι~< χρ Ο 1 C 1 <η < ΓΛ FM I ~ 1 0 «j -4 C >ι φ ?ι <3 /«.* *=» iS tS Χ3 ο ij Aj Φ C φ φ β — S <-"" » β 1 0 ^4 40 m e = ι=1 «—•pi 1 >1 ι e 03 Ω, 03 <3 1 Ο 1 ¢=-4 Κ»» &4 >, ί-Μ {X ΐΗ·-* >o C £ M φ > φ a «£: s <&M *** δ' Ift & X£·* O S ea w 0 Φ k k « o β te ki XI © w es ·© 0»M £S w Ή &.F-9 w m («-1 t£i H &£ « 3^i £ϊ te • 0 £*3 0 & K u & yj to o >O X β o o es κ *> ς? £ ut &n ^1 h s *3* 1 *U . • ·«.·©«© o fl >1 8 ^i>> P* n u P-ί ·-*-«£ <^9 <^jj ω * The data in Table V demonstrates that the method of improving feed effieency ,md promoting growth ean he practiced with aay desired mixture of 0*phen» ©thanolamine optical isomers.
The efficacy of the 9*pherathanolestine£ described herein also has been demonstrated in poultry. In a typical study, broilers that were twenty^oae days old were administered an oral dosing of a ^pheneth&nol® amine in their normal daily feed ration. All animals received the following broiler finisher ration: Ingredients X by wejoht Ibs/T jtq/t Ground yellow corn 66.40 1328.00 664.00 Animal-vegetable fat 1.63 30.60 15.30 Corn Glut, meal (60%) 4.00 80.00 40.00 Soybean meal (48%) 19.19 383.80 191.90 Fish meal«menhaden 2,50 50.00 25.00 Dicaleium phosphate 1.01 34.20 17.10 Feather meal-Hydr. 2.50 50.00 25.00 Ground limestone 0.83 16.60 8.30 Salt 0.30 6.00 3.00 Vitamin Prenix1 0.50 10.00 5.00 Trace mineral premix3 0.10 2.00 1.00 Methionine Hyd. Anal. 0.15 3.00 1.50 Lysine HCl 0.29 5.80 2.90 100.00 2000.00 1000.00 1 . * Vitamin premix provides ICU of vitcimin Ds, 40 mg 3000 IU of vitamin A, of vitamin E, 0.7 mg 900 of vitamin κ, 1000 a»g of choline, 70 mg of niacin, ag of pantothenic acid, 4 mo of riboflavin, 100 meg of vitamin 31St 100 meg of biotin and 125 mg of ethoxyguin per kg of complete feed.
Trace mineral premix provides 75 ag of manganese, mg of zinc,'25 mg of iron and 1 mg of iodine per kg of complete feed.
Test animals received with the above ration varying doses of l"(4-hydroxyphenyi)-2-[l-methyl-3-(4-hydroxyphenyl)propylaaino] go* ο fo O' es s ¢9 0 am y > y o e fci 0 0 u •rt (rt Q •b5 Eg *0 © C © •rt fe ¢9 0 0 •rt ea X. eJ fo 9 <9 © gj fi£ irt ©> •rt' fe 0 u ga nJ £ fcj & o Is esq © J> © > u C © © •pH fo *-4 <3 «9 O t£& β 0 ε «ϋ w •rt 0 «J lu x H btf © pH & o x« X» KO 3ff Ei O ¢8 &j fo O *=* 6? ω < 0 0 *3* O' Φ © O' © ϊ=1 ^=J I=j wgt M> CM CM t-3 & fi* CM n CM CM « CM CM CM CM CM CM Φ tM *Ί f* eA cn cn «Α cn O σ* i- ca e-J M3 -© &n «0 tn «0 »rt frt fM fM rtC coo© «-i CM *& <9 fo (¢3 < < < < O £ es £ £ 0 S3 3 3 S3 fo 0 0 0 0 <5} 0* Wi ex ex £ 65 8= C: IK 0 O O 0 0 u U 0 u » The results of this study demonstrate that the g-phenethanolamines described herein ere effective in promoting growth and improving feed efficiency in poultry.
The compounds of the invention also hove demonstrated efficacy in ruminants. Forty-eight cross® bred wether lambs were employed in a test designed to show the effects of Compound A (l-(4®hydroxyphenyl)2® Il"methyl-3"H-hydroxyphenyl )propyl amino] ethanol hydrochloride) st varying doses. Sixteen animals were held as controls, while sixteen received 40 ppm of Compound A, and another sixteen received 00 ppm of Compound A. All animals received a normal daily feed ration and water ad libitum. Average daily weight gain and average daily feed consumption after twenty^eight days is given below in Table Vll. The data demonstrates that a p^phenethanolamine as defined herein is effective in promoting growth and improving feed efficiency in ruminants.
Table vii Growth Performance of Lambs Treatment Dose i£2Si ADG (feg/lbs) ADF (kg/lbs) F/G 25 Control 0 0.188 0.414 1.869 3.68 8.89 Compound A 40 0.190 0.418 1.637 3-61 8.64 Compound A @0 0.214 0.472 1.619 3.57 7.56 *
Claims (11)
1. A method for promoting the growth, improving th® efficiency of feed utilisation or improving the leanness of © clousstieatecs animal e which comprises admin» 5 istering to said animal a costpound of the formula O): O’) os* an acid addition salt thereof·
2. O A method according to claim 1, for growth promotion» 10
3. method according to claim 1, for improving the efficiency of feed utilisation»
4. A method according to claim 1, for improving the leanness of a domesticated animal.
5. » A method according to any one of claims 1 to 15 wherein the compound of fonaula (I) is 1~ (^-hydroxyphenyl) -2« (l®methyl*=3“ (® -hydroKypheny 1) propy lamino J ethanol, hydrochloride.
6. A sietbod according to any one of claims 1 to 5 which comprises administering an active compound of 20 formula (X ) to pigs.
7. A nethod according to any one of claims 1 to 5 which comprises administering an active compound of formula (X) to cattle.
8. Φ An animal feed presaix comprising a g-phen25 ethanolamine of the formula (1) s or an acid addition salt thereof, associated with a suitable carrier therefor.
9. An animal feed premix as claimed in claim· 8, wherein the compound of formula (1) is in the form of 5 its hydrochloride.
10. A method according to claim l for promoting the growth, improving the efficiency of feed utilisation or improving the leanness of a domesticated animal, substantially as hereinbefore described and exemplfied. 10
11. ll. An animal feed premix according to claim 8, substantially as hereinbefore described and exemplified.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US46258783A | 1983-01-31 | 1983-01-31 | |
| IE211/84A IE56843B1 (en) | 1983-01-31 | 1984-01-30 | Phenethanolamine derivatives in weight control in animals |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE873337L IE873337L (en) | 1984-07-31 |
| IE56844B1 true IE56844B1 (en) | 1992-01-01 |
Family
ID=26318833
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE3337/87A IE56844B1 (en) | 1983-01-31 | 1984-01-30 | Phenethanolamine derivatives in weight control in animals |
Country Status (1)
| Country | Link |
|---|---|
| IE (1) | IE56844B1 (en) |
-
1984
- 1984-01-30 IE IE3337/87A patent/IE56844B1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IE873337L (en) | 1984-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0204948B1 (en) | Growth promotion of animals with phenethanol amines | |
| US4690951A (en) | Growth promotion | |
| US5232946A (en) | Phenylethanolamines, their use as pharmaceuticals and as performance enhancers in animals | |
| EP0026298B1 (en) | Method for promoting growth and reducing fat in animals using phenylethanolamine derivatives | |
| US4404222A (en) | Phenylethanolamine derivatives and acid addition salts thereof for enhancing the growth rate of meat-producing animals and improving the efficiency of feed utilization thereby | |
| US4407819A (en) | Phenylethanolamine derivatives and acid addition salts thereof for the depression of fat deposition in warm blooded animals | |
| AU645313B2 (en) | Improved process for resolution of racemic cimaterol;(-)- cimaterol and derivatives thereof | |
| EP0049728B1 (en) | Method for enhancing the growth rate of meat-producing animals and for improving the lean meat to fat ratio thereof | |
| US4992473A (en) | Growth promotion | |
| US5631298A (en) | Growth promotion | |
| US5393774A (en) | Phenylethanolamines, pharmaceutical compositions containing these compounds and process for preparing them | |
| US4734437A (en) | Growth promotion | |
| US4849453A (en) | Growth promotion | |
| IE56844B1 (en) | Phenethanolamine derivatives in weight control in animals | |
| US4501751A (en) | Phenylethanolamine derivatives and acid addition salts thereof for enhancing the growth rate of meat-producing animals and improving the efficiency of feed utilization thereby | |
| US4754047A (en) | Phenylethanolamine derivatives and acid addition salts thereof for enhancing the growth rate of meat-producing animals and/or improving the efficiency of feed utilization thereby | |
| HU196741B (en) | Process for producing fodder additive increasing the efficiency of animal husbandry, as well as aryl ethanole amines usable as active ingredient |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK9A | Patent expired |